{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:21:28Z","timestamp":1791901288855,"version":"4.3.4"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopha.2020.110874","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T23:07:52Z","timestamp":1602976072000},"page":"110874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The role of glycogen synthase kinase 3 beta in multiple sclerosis"],"prefix":"10.1016","volume":"132","author":[{"given":"Tayebeh","family":"Noori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Fakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2544","authenticated-orcid":false,"given":"Eduardo","family":"Sobarzo-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hosein","family":"Farzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"K\u00fcpeli Akkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyede Zahra","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyede Darya","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5000-3387","authenticated-orcid":false,"given":"Samira","family":"Shirooie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2020.110874_bib0005","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1242\/jcs.138057","article-title":"GSK-3 \u2013 at the crossroads of cell death and survival","volume":"127","author":"Maurer","year":"2014","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase kinase\u20103 from rabbit skeletal muscle: separation from cyclic\u2010AMP\u2010dependent protein kinase and phosphorylase kinase","volume":"107","author":"Embi","year":"1980","journal-title":"Eur. J. Biochem."},{"issue":"4-5","key":"10.1016\/j.biopha.2020.110874_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.biopha.2020.110874_bib0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10495-017-1376-0","article-title":"Role of glycogen synthase kinase following myocardial infarction and ischemia\u2013reperfusion","volume":"22","author":"Ghaderi","year":"2017","journal-title":"Apoptosis"},{"issue":"14","key":"10.1016\/j.biopha.2020.110874_bib0025","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1242\/jcs.007443","article-title":"Polarity proteins PAR6 and aPKC regulate cell death through GSK-3\u03b2 in 3D epithelial morphogenesis","volume":"120","author":"Kim","year":"2007","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2020.110874_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2011.00044","article-title":"Functions of GSK-3 signaling in development of the nervous system","volume":"4","author":"Kim","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.138","article-title":"p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase\/Akt\/GSK3 signaling","volume":"3","author":"Nayak","year":"2012","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2012.08.042","article-title":"Glycogen synthase kinase-3\u03b2 activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization","volume":"426","author":"Hongo","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.biopha.2020.110874_bib0045","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.yexcr.2011.06.004","article-title":"Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors","volume":"317","author":"Manceur","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3 \u03b2 by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0055","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/j.1460-2075.1990.tb07419.x","article-title":"Molecular cloning and expression of glycogen synthase kinase\u20103\/factor A","volume":"9","author":"Woodgett","year":"1990","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.biopha.2020.110874_bib0060","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2010.105","article-title":"Is glycogen synthase kinase-3 a central modulator in mood regulation?","volume":"35","author":"Li","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"21","key":"10.1016\/j.biopha.2020.110874_bib0065","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1111\/febs.12407","article-title":"Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia","volume":"280","author":"Cole","year":"2013","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.biopha.2020.110874_bib0070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2004.06.050","article-title":"A glycogen synthase kinase 3-\u03b2 promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression","volume":"368","author":"Benedetti","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/med.10011","article-title":"Glycogen synthase kinase 3 (GSK\u20103) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation","volume":"22","author":"Martinez","year":"2002","journal-title":"Med. Res. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0090","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/brain\/113.5.1477","article-title":"Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications","volume":"113","author":"Kermode","year":"1990","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0095","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.1011","article-title":"Correlation between neurological progression and astrocyte apoptosis in HIV\u2010associated dementia","volume":"49","author":"Thompson","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1-2","key":"10.1016\/j.biopha.2020.110874_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease","volume":"157","author":"McArthur","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110874_bib0110","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2014the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0166-2236(96)10047-3","article-title":"Cytokines in inflammatory brain lesions: helpful and harmful","volume":"19","author":"Merrill","year":"1996","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.170.2.607","article-title":"Tumor necrosis factor identified in multiple sclerosis brain","volume":"170","author":"Hofman","year":"1989","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2010.03.004","article-title":"Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis","volume":"32","author":"Kang","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0135","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awg107","article-title":"cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity","volume":"126","author":"Mycko","year":"2003","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5483\/BMBRep.2016.49.6.059","article-title":"Glycogen synthase kinase 3\u03b2 in Toll-like receptor signaling","volume":"49","author":"Ko","year":"2016","journal-title":"BMB Rep."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0145","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.neuint.2012.07.003","article-title":"GSK-3 mediates the release of IL-1\u03b2, TNF-\u03b1 and IL-10 from cortical glia","volume":"61","author":"Green","year":"2012","journal-title":"Neurochem. Int."},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0150","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s00109-005-0684-y","article-title":"Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis","volume":"83","author":"Booth","year":"2005","journal-title":"J. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2020.110874_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuroscience.2012.09.020","article-title":"Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action","volume":"226","author":"Mazzardo-Martins","year":"2012","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2010.06.007","article-title":"The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice","volume":"12","author":"Martins","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.biopha.2020.110874_bib0170","first-page":"6","article-title":"Recent advances in understanding the cellular roles of GSK-3","author":"Cormier","year":"2017","journal-title":"F1000Research"},{"issue":"15","key":"10.1016\/j.biopha.2020.110874_bib0175","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.M110.127969","article-title":"Distinct molecular regulation of glycogen synthase Kinase-3\u03b1 isozyme controlled by its N-terminal region FUNCTIONAL ROLE IN CALCIUM\/CALPAIN SIGNALING","volume":"286","author":"Azoulay-Alfaguter","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2002.00918.x","article-title":"Alternative splicing isoform of tau protein kinase I\/glycogen synthase kinase 3\u03b2","volume":"81","author":"Mukai","year":"2002","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0185","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1399-3011.1999.00083.x","article-title":"Expression analysis of glycogen synthase kinase\u20103 in human tissues","volume":"54","author":"Lau","year":"1999","journal-title":"J. Pept. Res."},{"issue":"51","key":"10.1016\/j.biopha.2020.110874_bib0195","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1021\/bi100822q","article-title":"Allosteric regulation of glycogen synthase kinase 3\u03b2: a theoretical study","volume":"49","author":"Buch","year":"2010","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3\u03b2: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.biopha.2020.110874_bib0205","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.2174\/1381612811319260007","article-title":"Design of glycogen synthase kinase-3 inhibitors: an overview on recent advancements","volume":"19","author":"Arfeen","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.2010.00661.x","article-title":"GSK3\u03b2: role in therapeutic landscape and development of modulators","volume":"160","author":"Phukan","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4861","key":"10.1016\/j.biopha.2020.110874_bib0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1126\/science.3291115","article-title":"The protein kinase family: conserved features and deduced phylogeny of the catalytic domains","volume":"241","author":"Hanks","year":"1988","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biopha.2020.110874_bib0220","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/89624","article-title":"Structure of GSK3\u03b2 reveals a primed phosphorylation mechanism","volume":"8","author":"ter Haar","year":"2001","journal-title":"Nat. Struct. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0225","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.bbrc.2008.10.096","article-title":"Effect of mutation K85R on GSK-3\u03b2: molecular dynamics simulation","volume":"377","author":"Sun","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0230","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3\u03b2 in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0235","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1038\/s41598-017-09239-5","article-title":"In vivo regulation of glycogen synthase kinase 3\u03b2 activity in neurons and brains","volume":"7","author":"Krishnankutty","year":"2017","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.biopha.2020.110874_bib0240","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00018-007-7045-7","article-title":"Glycogen synthase kinase 3: a key regulator of cellular fate","volume":"64","author":"Ja","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/1873-3468.12990","article-title":"Modulation of GSK3\u03b2 autoinhibition by Thr-7 and Thr-8","volume":"592","author":"Tong","year":"2018","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.biopha.2020.110874_bib0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/89624","article-title":"Structure of GSK3\u03b2 reveals a primed phosphorylation mechanism","volume":"8","author":"ter Haar","year":"2001","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/BJ20131182","article-title":"The role of the non-canonical Wnt\u2013planar cell polarity pathway in neural crest migration","volume":"457","author":"Mayor","year":"2014","journal-title":"Biochem. J."},{"issue":"19","key":"10.1016\/j.biopha.2020.110874_bib0260","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1242\/dev.033910","article-title":"Towards an integrated view of Wnt signaling in development","volume":"136","author":"van Amerongen","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.biopha.2020.110874_bib0265","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fphys.2014.00429","article-title":"Circadian rhythms, Wnt\/beta-catenin pathway and PPAR alpha\/gamma profiles in diseases with primary or secondary cardiac dysfunction","volume":"5","author":"Lecarpentier","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2020.110874_bib0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2016.03.008","article-title":"Intracellular signaling pathway regulation of myelination and remyelination in the CNS","volume":"283","author":"Gaesser","year":"2016","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0275","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1534-5807(03)00266-1","article-title":"A second canon: functions and mechanisms of \u03b2-catenin-independent Wnt signaling","volume":"5","author":"Veeman","year":"2003","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0280","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/glia.22813","article-title":"Canonical Wnt signaling in the oligodendroglial lineage\u2013puzzles remain","volume":"63","author":"Guo","year":"2015","journal-title":"Glia"},{"issue":"44","key":"10.1016\/j.biopha.2020.110874_bib0285","doi-asserted-by":"crossref","first-page":"16970","DOI":"10.1073\/pnas.0808616105","article-title":"Wnt-mediated self-renewal of neural stem\/progenitor cells","volume":"105","author":"Kalani","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2020.110874_bib0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fimmu.2016.00460","article-title":"Modulation of inflammatory responses by Wnt\/\u03b2-catenin signaling in dendritic cells: a novel immunotherapy target for autoimmunity and cancer","volume":"7","author":"Suryawanshi","year":"2016","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0295","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0300","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s12035-013-8584-6","article-title":"Wnt signaling in remyelination in multiple sclerosis: friend or foe?","volume":"49","author":"Xie","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nn.3676","article-title":"Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer","volume":"17","author":"Fancy","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0310","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.0802744","article-title":"Lymphoid enhancer binding factor 1 regulates transcription through gene looping","volume":"183","author":"Yun","year":"2009","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.biopha.2020.110874_bib0315","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1093\/nar\/gkm547","article-title":"\u03b2-Catenin binds to the downstream region and regulates the expression C-reactive protein gene","volume":"35","author":"Choi","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.biopha.2020.110874_bib0320","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1101\/gad.1806309","article-title":"Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS","volume":"23","author":"Fancy","year":"2009","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/\u03b2-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10571-011-9778-y","article-title":"Tcf7l2 is tightly controlled during myelin formation","volume":"32","author":"Fu","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1242\/jcs.00924","article-title":"PIKE GTPase: a novel mediator of phosphoinositide signaling","volume":"117","author":"Ye","year":"2004","journal-title":"J. Cell. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0340","first-page":"1","article-title":"Dual regulatory switch through interactions of Tcf7l2\/Tcf4 with stage-specific partners propels oligodendroglial maturation","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0345","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3892\/mmr.2017.6843","article-title":"Transcription factor 7 like 2 promotes oligodendrocyte differentiation and remyelination","volume":"16","author":"Weng","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0350","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nn.2855","article-title":"Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination","volume":"14","author":"Fancy","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0355","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s11481-012-9370-3","article-title":"Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain","volume":"7","author":"Yuan","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"39","key":"10.1016\/j.biopha.2020.110874_bib0360","doi-asserted-by":"crossref","first-page":"13921","DOI":"10.1523\/JNEUROSCI.3343-11.2011","article-title":"SRY-box containing gene 17 regulates the Wnt\/\u03b2-catenin signaling pathway in oligodendrocyte progenitor cells","volume":"31","author":"Chew","year":"2011","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2020.110874_bib0365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nn.2333","article-title":"HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the \u03b2-catenin\u2013TCF interaction","volume":"12","author":"Ye","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"7291","key":"10.1016\/j.biopha.2020.110874_bib0370","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nature08875","article-title":"APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex","volume":"464","author":"Shimomura","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110874_bib0375","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fimmu.2016.00378","article-title":"Crosstalk between Wnt\/\u03b2-catenin and NF-\u03baB signaling pathway during inflammation","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0380","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.26042","article-title":"Beta\u2010catenin\u2013NF\u2010\u03baB interactions in murine hepatocytes: a complex to die for","volume":"57","author":"Nejak\u2010Bowen","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.devcel.2009.05.011","article-title":"Reciprocal requirements for EDA\/EDAR\/NF-kappaB and Wnt\/beta-catenin signaling pathways in hair follicle induction","volume":"17","author":"Zhang","year":"2009","journal-title":"Dev. Cell"},{"issue":"45","key":"10.1016\/j.biopha.2020.110874_bib0390","doi-asserted-by":"crossref","first-page":"42276","DOI":"10.1074\/jbc.M104227200","article-title":"Regulation of beta-catenin function by the IkappaB kinases","volume":"276","author":"Lamberti","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0395","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1091\/mbc.02-06-0101","article-title":"IKK\u03b1 regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf","volume":"14","author":"Albanese","year":"2003","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0400","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0802907","article-title":"Regulation of PPAR \u03b3 activity during adipogenesis","volume":"29","author":"Farmer","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2020.110874_bib0405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijdevneu.2014.03.006","article-title":"Dysregulation of the IGF-I\/PI3K\/AKT\/mTOR signaling pathway in autism spectrum disorders","volume":"35","author":"Chen","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2020.110874_bib0410","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/nm.2984","article-title":"Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways","volume":"18","author":"Huang","year":"2012","journal-title":"Nat. Med."},{"issue":"Pt B","key":"10.1016\/j.biopha.2020.110874_bib0415","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.expneurol.2016.03.008","article-title":"Intracellular signaling pathway regulation of myelination and remyelination in the CNS","volume":"283","author":"Gaesser","year":"2016","journal-title":"Exp. Neurol."},{"issue":"46","key":"10.1016\/j.biopha.2020.110874_bib0420","doi-asserted-by":"crossref","first-page":"16853","DOI":"10.1073\/pnas.0507365102","article-title":"Phosphoinositol lipids bind to phosphatidylinositol 3 (PI3)-kinase enhancer GTPase and mediate its stimulatory effect on PI3-kinase and Akt signalings","volume":"102","author":"Hu","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2020.110874_bib0425","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.0712306105","article-title":"Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion","volume":"105","author":"Liu","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0430","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.22090","article-title":"Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination","volume":"68","author":"Harrington","year":"2010","journal-title":"Ann. Neurol."},{"issue":"26","key":"10.1016\/j.biopha.2020.110874_bib0435","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1523\/JNEUROSCI.0219-10.2010","article-title":"Elevated phosphatidylinositol 3, 4, 5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination","volume":"30","author":"Goebbels","year":"2010","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.biopha.2020.110874_bib0440","doi-asserted-by":"crossref","first-page":"6860","DOI":"10.1523\/JNEUROSCI.0232-09.2009","article-title":"Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination","volume":"29","author":"Narayanan","year":"2009","journal-title":"J. Neurosci."},{"issue":"48","key":"10.1016\/j.biopha.2020.110874_bib0445","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1523\/JNEUROSCI.3360-14.2014","article-title":"Role of ERK1\/2 MAPK signaling in the maintenance of myelin and axonal integrity in the adult CNS","volume":"34","author":"Ishii","year":"2014","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0450","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.4049\/jimmunol.1400614","article-title":"TLR2-dependent activation of \u03b2-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation","volume":"193","author":"Manoharan","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0455","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2007.08.015","article-title":"Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation","volume":"27","author":"Jiang","year":"2007","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020099","article-title":"TGF-\u03b2 suppresses \u03b2-catenin-dependent tolerogenic activation program in dendritic cells","volume":"6","author":"Vander Lugt","year":"2011","journal-title":"PLoS One"},{"issue":"39","key":"10.1016\/j.biopha.2020.110874_bib0465","doi-asserted-by":"crossref","first-page":"27825","DOI":"10.1074\/jbc.M112.425751","article-title":"Fas signal promotes the immunosuppressive function of regulatory dendritic cells via the ERK\/\u03b2-catenin pathway","volume":"288","author":"Qian","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0470","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tibs.2016.10.009","article-title":"Stressed and inflamed, can GSK3 Be blamed?","volume":"42","author":"Jope","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0475","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/14728222.2018.1526925","article-title":"Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging","volume":"22","author":"Duda","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086466","article-title":"Mycobacteria bypass mucosal NF-kB signalling to induce an epithelial anti-inflammatory IL-22 and IL-10 response","volume":"9","author":"Lutay","year":"2014","journal-title":"PLoS One"},{"issue":"6791","key":"10.1016\/j.biopha.2020.110874_bib0485","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110874_bib0495","doi-asserted-by":"crossref","first-page":"38553","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0500","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11357-019-00085-z","article-title":"An expanding GSK3 network: implications for aging research","volume":"41","author":"Souder","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.biopha.2020.110874_bib0505","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2018.07.006","article-title":"Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: opportunities, challenges and future directions for cerebral stroke management","volume":"139","author":"Rana","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5876","key":"10.1016\/j.biopha.2020.110874_bib0510","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.1156037","article-title":"Phosphorylation by p38 MAPK as an alternative pathway for GSK3\u03b2 inactivation","volume":"320","author":"Thornton","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.biopha.2020.110874_bib0515","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnmol.2011.00018","article-title":"Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases","volume":"4","author":"Beurel","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0520","first-page":"136-","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110874_bib0525","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3\u03b2 inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat*","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110874_bib0530","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/01.CCM.0000178350.21839.44","article-title":"GSK-3\u03b2 inhibitors attenuate the organ injury\/dysfunction caused by endotoxemia in the rat","volume":"33","author":"Dugo","year":"2005","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.biopha.2020.110874_bib0535","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0706509","article-title":"Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase\u20103\u03b2","volume":"147","author":"Whittle","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2006.03.005","article-title":"Glycogen synthase kinase-3\u03b2 inhibition attenuates the degree of arthritis caused by type II collagen in the mouse","volume":"120","author":"Cuzzocrea","year":"2006","journal-title":"Clin. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2020.110874_bib0545","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.14379","article-title":"The role of Nrf2 signaling in counteracting neurodegenerative diseases","volume":"285","author":"Dinkova-Kostova","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2020.110874_bib0550","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419899782","article-title":"NRF2 as a therapeutic target in neurodegenerative diseases","volume":"12","author":"Brandes","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.biopha.2020.110874_bib0555","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intimp.2018.10.008","article-title":"Anti-inflammatory effects of isoalantolactone on LPS-stimulated BV2 microglia cells through activating GSK-3\u03b2-Nrf2 signaling pathway","volume":"65","author":"Wang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2020.110874_bib0560","doi-asserted-by":"crossref","first-page":"1043-","DOI":"10.12688\/f1000research.15239.1","article-title":"GSK-3\u03b2, a double-edged sword in Nrf2 regulation: Implications for neurological dysfunction and disease","volume":"7","author":"Culbreth","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.biopha.2020.110874_bib0565","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0570","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/genes11080939","article-title":"Wnt\/\u03b2-catenin signaling in tissue self-organization","volume":"11","author":"Pond","year":"2020","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0575","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5115\/acb.2017.50.1.48","article-title":"Potential involvement of glycogen synthase kinase (GSK)-3\u03b2 in a rat model of multiple sclerosis: evidenced by lithium treatment","volume":"50","author":"Ahn","year":"2017","journal-title":"Anat. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0580","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.biopha.2020.110874_bib0585","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.neuroscience.2014.07.013","article-title":"Inactive GSK3\u03b2 is disturbed in the spinal cord during experimental autoimmune encephalomyelitis, but rescued by stem cell therapy","volume":"277","author":"Tafreshi","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0590","first-page":"001-","article-title":"The role of glycogen synthase kinase 3 beta in neuroinflammation and pain","volume":"1","author":"Maixner","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0595","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1007\/s12035-015-9326-8","article-title":"Loss of GSK-3 causes abnormal astrogenesis and behavior in mice","volume":"53","author":"Jung","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2020.110874_bib0600","article-title":"GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration","volume":"2011","author":"Salcedo-Tello","year":"2011","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0605","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5607\/en.2013.22.2.59","article-title":"Brain inflammation and microglia: facts and misconceptions","volume":"22","author":"Jeong","year":"2013","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0610","first-page":"bio030874","article-title":"The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of \u03b2-catenin, a GSK3 substrate, in human glioblastoma cells","volume":"7","author":"Aurm","year":"2018","journal-title":"Biol. Open"},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0615","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imm.13199","article-title":"Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production","volume":"160","author":"Han","year":"2020","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.biopha.2020.110874_bib0620","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110874_bib0625","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110874_bib0630","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0635","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4049\/jimmunol.0804033","article-title":"Glycogen synthase kinase-3beta facilitates IFN-gamma-induced STAT1 activation by regulating Src homology-2 domain-containing phosphatase 2","volume":"183","author":"Tsai","year":"2009","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2020.110874_bib0640","first-page":"e275","article-title":"Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS\/NO biosynthesis and RANTES production in microglial cells","volume":"128","author":"Huang","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2020.110874_bib0645","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2017.10.016","article-title":"A partnership with the proteasome; the destructive nature of GSK3","volume":"147","author":"Robertson","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110874_bib0650","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnmol.2011.00018","article-title":"Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases","volume":"4","author":"Beurel","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0655","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cyto.2010.10.009","article-title":"Glycogen synthase kinase 3: a point of convergence for the host inflammatory response","volume":"53","author":"Wang","year":"2011","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0660","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4049\/jimmunol.1001473","article-title":"The role of glycogen synthase kinase 3 in regulating IFN-\u03b2-mediated IL-10 production","volume":"186","author":"Wang","year":"2011","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0665","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bph.12098","article-title":"Glycogen synthase kinase-3 (GSK-3) regulates TGF-\u03b2\u2081-induced differentiation of pulmonary fibroblasts","volume":"169","author":"Baarsma","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2020.110874_bib0670","doi-asserted-by":"crossref","first-page":"14226","DOI":"10.1074\/jbc.M111.308841","article-title":"Protein kinase C \u03b4 (PKC\u03b4)-extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia","volume":"287","author":"Noh","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2020.110874_bib0675","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuroscience.2010.05.044","article-title":"Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes","volume":"169","author":"Beurel","year":"2010","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.biopha.2020.110874_bib0680","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.18632\/aging.100853","article-title":"Age-related neuroinflammation and changes in AKT-GSK-3\u03b2 and WNT\/ \u03b2-CATENIN signaling in rat hippocampus","volume":"7","author":"Orellana","year":"2015","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0685","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3892\/or.2015.4043","article-title":"Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of \u03b2-catenin expression via EP3-4 receptor","volume":"34","author":"Du","year":"2015","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0690","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1074\/jbc.M111.323337","article-title":"Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity","volume":"287","author":"Valvezan","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0695","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.148.4.691","article-title":"Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification","volume":"148","author":"Farr","year":"2000","journal-title":"J. Cell Biol."},{"issue":"23","key":"10.1016\/j.biopha.2020.110874_bib0700","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1158\/0008-5472.CAN-05-0599","article-title":"Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B","volume":"65","author":"Skov","year":"2005","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0705","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/cells9040820","article-title":"GSK3: a kinase balancing promotion and resolution of inflammation","volume":"9","author":"Hoffmeister","year":"2020","journal-title":"Cells"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2020.110874_bib0710","first-page":"e275","article-title":"Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS\/NO biosynthesis and RANTES production in microglial cells","volume":"128","author":"Huang","year":"2009","journal-title":"Immunology"},{"issue":"32","key":"10.1016\/j.biopha.2020.110874_bib0715","doi-asserted-by":"crossref","first-page":"21934","DOI":"10.1074\/jbc.M802481200","article-title":"Differential regulation of STAT family members by glycogen synthase kinase-3","volume":"283","author":"Beurel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110874_bib0720","doi-asserted-by":"crossref","first-page":"43545","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis","volume":"7","author":"Medina-Rodr\u00edguez","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0725","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12035-014-8678-9","article-title":"GSK3\u03b2 promotes the differentiation of oligodendrocyte precursor cells via \u03b2-catenin-mediated transcriptional regulation","volume":"50","author":"Zhou","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110874_bib0730","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/13543776.2017.1259412","article-title":"Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)","volume":"27","author":"Palomo","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"460","key":"10.1016\/j.biopha.2020.110874_bib0735","article-title":"Modulation of inflammatory responses by Wnt\/\u03b2-catenin signaling in dendritic cells: a novel immunotherapy target for autoimmunity and Cancer","volume":"7","author":"Suryawanshi","year":"2016","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110874_bib0740","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pneurobio.2006.07.006","article-title":"The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways","volume":"79","author":"Beurel","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biopha.2020.110874_bib0745","doi-asserted-by":"crossref","first-page":"861072","DOI":"10.4061\/2011\/861072","article-title":"Regulation of cell survival mechanisms in Alzheimer\u2019s disease by glycogen synthase kinase-3","volume":"2011","author":"Mines","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2020.110874_bib0750","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5386","article-title":"Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators","volume":"6","author":"Corigliano","year":"2018","journal-title":"PeerJ."},{"issue":"2","key":"10.1016\/j.biopha.2020.110874_bib0755","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(01)03242-5","article-title":"Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons","volume":"924","author":"Uryu","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2020.110874_bib0760","doi-asserted-by":"crossref","first-page":"745-","DOI":"10.3389\/fimmu.2018.00745","article-title":"Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-Catenin pathway in chronic inflammation and oxidative stress during carcinogenesis","volume":"9","author":"Vall\u00e9e","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2020.110874_bib0765","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/961753","article-title":"A role for PPARgamma in the regulation of cytokines in immune cells and cancer","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2020.110874_bib0770","first-page":"257","article-title":"TDZD\u2019s: selective and ATP noncompetitive glycogen synthase kinase 3 inhibitors. Glycogen synthase kinase 3 (GSK-3) and its inhibitors","volume":"3","author":"Castro","year":"2006","journal-title":"Drug Discov. Dev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:07:29Z","timestamp":1760098049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220310660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":154,"alternative-id":["S0753332220310660"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110874","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of glycogen synthase kinase 3 beta in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110874"}}